← Back to patent-cliff list
CAS 5307-14-2
2-Nitro-1,4-phenylenediamine2-nitrobenzene-1,4-diamine
Codes: Sodium ilaprazole-001, ILAP-001
Application context (from source-drug indications)
Peptic ulcerSodium ilaprazolePeptic ulcer bleedingSodium ilaprazoleDuodenal ulcerSodium ilaprazoleGastric ulcerSodium ilaprazolePeptic oesophagitisSodium ilaprazoleDuodenal ulcerIlaprazoleGastro-oesophageal reflux diseaseIlaprazolePeptic ulcer bleedingIlaprazoleOesophagitisIlaprazole
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Sodium ilaprazole | Tier C — Watch / trade | - |
| Ilaprazole | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-Nitro-1,4-phenylenediamine→2,5-Dimethoxytetrahydrofuran→2-Nitro-4-(1H-pyrrol-1-yl)aniline→4-(1H-Pyrrol-1-yl)benzene-1,2-diamine→Carbon disulfide→5-(1H-Pyrrol-1-yl)-1H-benzimidazole-2-thiol→2-(Chloromethyl)-4-methoxy-3-methylpyridine→2-(Chloromethyl)-4-methoxy-3-methylpyridine hydrogen chloride→2-[[(4-Methoxy-3-methylpyridin-2-yl)methyl]sulfanyl]-5-(1H-pyrrol-1-yl)-1H-benzimidazole
2-nitrobenzene-1,4-diamine→2,5-dimethoxytetrahydrofuran→2-nitro-4-(1H-pyrrol-1-yl)aniline→4-(1H-pyrrol-1-yl)benzene-1,2-diamine→5-(1H-pyrrol-1-yl)-1H-benzo[d]imidazole-2-thiol→2-(chloromethyl)-4-methoxy-3-methylpyridine hydrochloride→2-(((4-methoxy-3-methylpyridin-2-yl)methyl)thio)-5-(1H-pyrrol-1-yl)-1H-benzo[d]imidazole→Ilaprazole
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.